摘要
肺腺癌是肺癌的常见类型,但多数确诊时已属晚期。虽然目前无法治愈,但随着研究的不断深入、技术的不断完善,针对晚期肺腺癌的治疗方法如化疗、分子靶向治疗、化疗与靶向药物间插联合疗法、免疫治疗等正逐渐趋于精准化、个体化,使患者生存时间延长、生活质量提高。本文就现行的治疗方法作简要综述。
Lung adenocarcinoma is the most common pathological type of lung cancer,but in most cases it has already locally advanced or distantly metastasized when diagnosed. It can't be cured at present, but with the development of the research and technology, many treatment methods for advanced lung adenocarcinoma will be gradually accurate and individual, for example, chemotherapy, molecular targeted therapy,intercalated combination therapy,immunotherapy and so on. These therapeutic regimens bring about substantial prolongation of survival life and improvement in life quality for those advanced lung adenocarcinoma patients. In this article, we will make a brief review for the current treatment strategies.
出处
《国际呼吸杂志》
2015年第22期1734-1738,共5页
International Journal of Respiration
关键词
晚期肺腺癌
化疗
分子靶向治疗
间插联合疗法
免疫治疗
个体化
Advanced lung adenocarcinoma
Chemotherapy
Molecular targeted therapy
Intercalated combination therapy
Immunotherapy
Individual